Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07041177 · ClinicalTrials.gov registry record · NA
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open Wounds
A NA study of Open Wound, sponsored by NuScience Medical Biologics.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT07041177 is a NA study of Open Wound that is actively recruiting participants, run by NuScience Medical Biologics. The registered enrollment target is 10 participants, below the 62-participant average among 3 other Open Wound trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07041177, a NA study of Open Wound, is actively recruiting participants, sponsored by NuScience Medical Biologics.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Open Wounds
Conditions Studied
Interventions
- OTHER NeoThelium FT
Study Locations (1)
Louisiana
- MedCentris of Hammond - Hammond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-08-25 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07041177
The ClinicalTrials.gov registry entry for NCT07041177 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 62-participant average among 3 other Open Wound trials with a reported enrollment target (84% lower). The listed sponsor is NuScience Medical Biologics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Open Wound appearing as the primary indexed condition, and to 1 intervention - of which NeoThelium FT is the first listed.
NCT07041177 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT07041177 about?
NCT07041177 is a clinical study titled "Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Open Wounds". This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Open Wounds
What is the current status of trial NCT07041177?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-08-25. Estimated completion is 2026-04-01.
What conditions does trial NCT07041177 study?
This clinical trial studies the following conditions: Open Wound.
What interventions are being tested in trial NCT07041177?
The interventions under investigation include: NeoThelium FT (OTHER).
Who is sponsoring clinical trial NCT07041177?
This trial is sponsored by NuScience Medical Biologics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07041177 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Wound
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.